In a dramatic reversal of fortune, Hims & Hers Health (NYSE:HIMS) has been rescued by the very company that nearly sank it.

Novo Nordisk reportedly will sell its weight-loss drugs via Hims and Hers after a legal feud. Hims and Hers stock surged late ...

March 6 () - Wegovy maker Novo ‌Nordisk plans to ‌sell its weight-loss drugs ​on Hims & Hers Health platform, bringing an end ...

Novo Nordisk A/S plans to sell its weight-loss drugs on Hims & Hers Health Inc.’s platform, according to a person familiar ...

Expansion is Hims & Hers' game plan, as it looks to broaden its product offerings. As its brand gains traction in the ...

Hims & Hers (HIMS) stock surged 39% after-hours on news of a partnership with Novo Nordisk (NVO) to sell weight loss drugs, ...

Novo is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe patents, and is ...

Wondering whether Hims & Hers Health is starting to look attractively priced, or if the market is still getting ahead of ...

Shares of Hims & Hers Health, Inc. HIMS are rising Monday after Secretary of Health and Human Services Robert F. Kennedy Jr.

Hims & Hers (HIMS) stock falls as the FDA send warning letters to telehealth firms that illegally market low-cost compounded ...

Hims & Hers executives struck a confident tone about the company's growth prospects Monday as it launches new specialties and ...

March 6 (Reuters) - Wegovy maker Novo Nordisk plans to sell its weight-loss drugs on Hims & Hers Health platform, bringing an ...